BEZCİ, K. Et Al. 2017. Investigation Of CYP2C9 2 Polymorphism In Patients With Cardiovascular Disease Using Warfarin. 4th ESPT Conference. Pharmacogenomics and Personalised Medicine: Research Progress and Clinical Implementation , (Catalunya, Spain).

BEZCİ, K., ÇEVİK, M., GEZER, E., ÜLKER , M., ÇATMAZ, Ö., YURDAKUL , S., ... ELÇİOĞLU CENGİZ, B.(2017). Investigation Of CYP2C9 2 Polymorphism In Patients With Cardiovascular Disease Using Warfarin . 4th ESPT Conference. Pharmacogenomics and Personalised Medicine: Research Progress and Clinical Implementation, Catalunya, Spain

BEZCİ, KIVANÇ Et Al. "Investigation Of CYP2C9 2 Polymorphism In Patients With Cardiovascular Disease Using Warfarin," 4th ESPT Conference. Pharmacogenomics and Personalised Medicine: Research Progress and Clinical Implementation, Catalunya, Spain, 2017

BEZCİ, KIVANÇ Et Al. "Investigation Of CYP2C9 2 Polymorphism In Patients With Cardiovascular Disease Using Warfarin." 4th ESPT Conference. Pharmacogenomics and Personalised Medicine: Research Progress and Clinical Implementation , Catalunya, Spain, 2017

BEZCİ, K. Et Al. (2017) . "Investigation Of CYP2C9 2 Polymorphism In Patients With Cardiovascular Disease Using Warfarin." 4th ESPT Conference. Pharmacogenomics and Personalised Medicine: Research Progress and Clinical Implementation , Catalunya, Spain.

@conferencepaper{conferencepaper, author={KIVANÇ BEZCİ Et Al. }, title={Investigation Of CYP2C9 2 Polymorphism In Patients With Cardiovascular Disease Using Warfarin}, congress name={4th ESPT Conference. Pharmacogenomics and Personalised Medicine: Research Progress and Clinical Implementation}, city={Catalunya}, country={Spain}, year={2017}}